SEC Form 4 · accession 0000899866-18-000047
ALEXION PHARMACEUTICALS, INC. · ALXN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Heidi L Wagner
Officer — SVP, Global Government Affairs
Period of report
Feb 27, 2018
Accepted (ET)
Mar 1, 2018 · 5:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000899866
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $.0001 per shareF1 | Feb 27, 2018 | S | 244 | $120.72 | D | 49,594 | D | |
| Common Stock, par value $.0001 per shareF1 | Feb 28, 2018 | S | 454 | $118.61 | D | 49,140 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.